The reasons are far-reaching and include stress, physical issues, anxiety, and even too much coffee - sometimes, there is no simple explanation
Eli Lilly said Thursday it plans to file for regulatory approval of its next-generation weight loss drug retatrutide in the first quarter of 2027, pushing back a timeline the company had previously indicated could come before the end of this year
Similarly, if comorbidities have worsened or new conditions developed, these require investigation and management that may indirectly improve weight loss response
Because metformin on its own carries very little hypoglycemia risk, this pairing rarely calls for any change to your existing metformin dose
If you're interested in finding out which supplements may be best for your specific needs, we invite you to take our AI quiz here
GLP-1 agonists are peptides that mimic the natural GLP-1 hormone present in the body to release insulin and suppress the release of glucagon in response to eating, thereby lowering blood sugar